Low-frequency of RABL3 pathogenetic variants in hereditary and familial pancreatic cancer.

[1]  M. Falconi,et al.  Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group. , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[2]  Walter G. Park,et al.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium , 2019, Gut.

[3]  Carol L. Williams,et al.  Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer , 2019, Nature Genetics.

[4]  D. Bartsch,et al.  Progress report: familial pancreatic cancer , 2019, Familial Cancer.

[5]  C. Bassi,et al.  Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry , 2018, The American Journal of Gastroenterology.

[6]  Qiong Liang,et al.  Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. , 2017, Human pathology.

[7]  Ewout W Steyerberg,et al.  Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Jian Sun,et al.  High Expression of Rabl3 is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8/9/10-Mediated Autophagy , 2016, Medical science monitor : international medical journal of experimental and clinical research.